Subscribe to Seeking Alpha feed
https://seekingalpha.com
URL: https://seekingalpha.com
Updated: 1 hour 43 min ago

Silvaco: The Turnaround Needs Cash Receipts To Match Its Technical Promise

Tue, 09/22/2026 - 14:38

Textron marks Aerosonde UAS flight, 500th Citation Latitude rollout

Tue, 09/22/2026 - 14:34

Edgewise Therapeutics, Inc. (EWTX) Discusses Differentiated Mechanism of Action of Cardiac Sarcomere Modulator EDG-7500 - Slideshow

Tue, 09/22/2026 - 14:33

Minerals Technologies Inc. (MTX) Analyst/Investor Day - Slideshow

Tue, 09/22/2026 - 14:32

Eledon Pharmaceuticals, Inc. (ELDN) Presents at International Congress of The Transplantation Society 2026 - Slideshow

Tue, 09/22/2026 - 14:32

Meta: AI Monetization Potential Is Finally Evident

Tue, 09/22/2026 - 14:27

Invesco Summit Fund Q2 2026 Commentary

Tue, 09/22/2026 - 14:27

Arhaus: Despite Industry Woes, The Company Offers Promise

Tue, 09/22/2026 - 14:24

InfraCap MLP ETF Q2 2026 Commentary

Tue, 09/22/2026 - 14:24

Leidos wins Army contract worth up to $127 million

Tue, 09/22/2026 - 14:21

UBS: The Decline Is Not Surprising To Me Given Regulation Updates

Tue, 09/22/2026 - 14:19

Abbott: Quality Remains, But Exact Sciences Has Raised The Bar For Buy

Tue, 09/22/2026 - 14:19

BlackRock Dynamic High Income Fund Q2 2026 Commentary

Tue, 09/22/2026 - 14:16

AMD At $1 Trillion: Gamma Squeeze Unlikely To Last Forever

Tue, 09/22/2026 - 14:13

John Hancock Classic Value Fund Q2 2026 Commentary

Tue, 09/22/2026 - 14:09

Lifetime Brands: Q2'26 Aided By Tariff Refunds

Tue, 09/22/2026 - 14:05

2027: The Year The CRE Debt Maturity Wall Triggers Peak Pain

Tue, 09/22/2026 - 14:01

Columbia High Yield Municipal Fund Q2 2026 Commentary

Tue, 09/22/2026 - 14:01

Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria - Slideshow

Tue, 09/22/2026 - 14:00

Western Asset Intermediate-Term Municipals Fund Q2 2026 Commentary

Tue, 09/22/2026 - 14:00

Pages